Business Description
Molecure SA
ISIN : PLONCTH00011
Compare
Compare
Traded in other countries / regions
MOC.Poland1B1.Germany IPO Date
2018-04-19Description
Molecure SA is a biopharmaceutical company engaged in discovering, developing, and commercializing novel therapeutics for neoplastic and inflammatory diseases. The company is focused on discovering and developing molecules with potential to become first-in-class or best-in-class drugs worldwide to treat unmet medical needs.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.91 | |||||
| Equity-to-Asset | 0.87 | |||||
| Debt-to-Equity | 0.07 | |||||
| Debt-to-EBITDA | -0.38 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Book Growth Rate | -4.6 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.53 | |||||
| 9-Day RSI | 57.25 | |||||
| 14-Day RSI | 53.33 | |||||
| 6-1 Month Momentum % | -12.66 | |||||
| 12-1 Month Momentum % | -27.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.79 | |||||
| Quick Ratio | 5.79 | |||||
| Cash Ratio | 5.56 | |||||
| Days Payable | 1103.13 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.2 | |||||
| Shareholder Yield % | -0.1 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -14.64 | |||||
| ROA % | -13.52 | |||||
| ROIC % | -27.5 | |||||
| ROC (Joel Greenblatt) % | -168.17 | |||||
| ROCE % | -14.06 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 92.94 | |||||
| PB Ratio | 2.81 | |||||
| Price-to-Tangible-Book | 5.32 | |||||
| EV-to-EBIT | -11.43 | |||||
| EV-to-EBITDA | -12.64 | |||||
| EV-to-FCF | -4.09 | |||||
| Price-to-Net-Current-Asset-Value | 6.65 | |||||
| Price-to-Net-Cash | 7.01 | |||||
| Earnings Yield (Greenblatt) % | -8.75 | |||||
| FCF Yield % | -20.36 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Molecure SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil zł) | |||
| EPS (TTM) (zł) | -1.17 | ||
| Beta | 1.87 | ||
| Volatility % | 35.73 | ||
| 14-Day RSI | 53.33 | ||
| 14-Day ATR (zł) | 0.587695 | ||
| 20-Day SMA (zł) | 14.981 | ||
| 12-1 Month Momentum % | -27.65 | ||
| 52-Week Range (zł) | 14.14 - 25.5 | ||
| Shares Outstanding (Mil) | 16.84 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Molecure SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Molecure SA Stock Events
| Event | Date | Price(zł) | ||
|---|---|---|---|---|
| No Event Data | ||||
Molecure SA Frequently Asked Questions
What is Molecure SA(WAR:MOC)'s stock price today?
The current price of WAR:MOC is zł15.70. The 52 week high of WAR:MOC is zł25.50 and 52 week low is zł14.14.
When is next earnings date of Molecure SA(WAR:MOC)?
The next earnings date of Molecure SA(WAR:MOC) is .
Does Molecure SA(WAR:MOC) pay dividends? If so, how much?
Molecure SA(WAR:MOC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers